CMA accuses four pharmaceutical companies of breaking competition law on supply of antidepressant

The Competition and Markets Authority has provisionally found four pharmaceutical companies to have broken completion law in relation to supply of nortriptyline, a tricyclic antidepressant.
Source: The Pharmaceutical Journal - Category: Drugs & Pharmacology Source Type: research